Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Holland

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Infection and Drug Resistance|December 11, 2012
Current management options for latent tuberculosis: a reviewBrianna L Norton, David P Holland
American Journal of Public Health|May 17, 2019
QuantiFERON-TB Gold Versus Tuberculin Screening and Care Retention Among Persons Experiencing Homelessness: Georgia, 2015-2017Jeffrey M Collins, Udodirim Onwubiko, David P Holland
Plos One|June 22, 2019
Using Directly Observed Therapy (DOT) for latent tuberculosis treatment - A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GAUdodirim Onwubiko, Kristin Wall, Rose-Marie Sales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2016
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a ThingSusanna Naggie, David P Holland, Mark S Sulkowski, et al.
JAMA Network Open|September 15, 2022
Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical TrialTsegahun Manyazewal, Yimtubezinash Woldeamanuel, Abebaw Fekadu, et al.
Plos One|July 27, 2011
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infectionDavid P Holland, Gillian D Sanders, Carol D Hamilton, et al.
North Carolina Medical Journal|October 30, 2013
Translating tuberculosis research into practice: collaboration between academic researchers and public health departments in North CarolinaDavid P Holland, Emily J Hecker, Ann W Mosher, et al.
Fertility and Sterility|July 29, 2010
Diagnosis of pelvic tuberculosis in a patient with tubal infertilityJohn R Crochet, Kristina C Hawkins, David P Holland, et al.
Journal of Behavioral Medicine|April 8, 2022
Association between having a regular healthcare provider and pre-exposure prophylaxis use among men who have sex with men: a cross-sectional surveyEleanor W Garlow, Udodirim N Onwubiko, David P Holland, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 1, 2007
Lateral diffusion coefficients of an eicosanyl-based bisglycerophosphocholine determined by PFG-NMR and FRAPWilma Febo-Ayala, David P Holland, Scott A Bradley, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Infection and Drug Resistance|December 11, 2012
Current management options for latent tuberculosis: a reviewBrianna L Norton, David P Holland
American Journal of Public Health|May 17, 2019
QuantiFERON-TB Gold Versus Tuberculin Screening and Care Retention Among Persons Experiencing Homelessness: Georgia, 2015-2017Jeffrey M Collins, Udodirim Onwubiko, David P Holland
Plos One|June 22, 2019
Using Directly Observed Therapy (DOT) for latent tuberculosis treatment - A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GAUdodirim Onwubiko, Kristin Wall, Rose-Marie Sales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2016
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a ThingSusanna Naggie, David P Holland, Mark S Sulkowski, et al.
JAMA Network Open|September 15, 2022
Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical TrialTsegahun Manyazewal, Yimtubezinash Woldeamanuel, Abebaw Fekadu, et al.
Plos One|July 27, 2011
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infectionDavid P Holland, Gillian D Sanders, Carol D Hamilton, et al.
North Carolina Medical Journal|October 30, 2013
Translating tuberculosis research into practice: collaboration between academic researchers and public health departments in North CarolinaDavid P Holland, Emily J Hecker, Ann W Mosher, et al.
Fertility and Sterility|July 29, 2010
Diagnosis of pelvic tuberculosis in a patient with tubal infertilityJohn R Crochet, Kristina C Hawkins, David P Holland, et al.
Journal of Behavioral Medicine|April 8, 2022
Association between having a regular healthcare provider and pre-exposure prophylaxis use among men who have sex with men: a cross-sectional surveyEleanor W Garlow, Udodirim N Onwubiko, David P Holland, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 1, 2007
Lateral diffusion coefficients of an eicosanyl-based bisglycerophosphocholine determined by PFG-NMR and FRAPWilma Febo-Ayala, David P Holland, Scott A Bradley, et al.
Pageof 6